| Filed On | Filing |
|---|---|
| 18 Feb 2025 |
8-K/A: Regulation FD Disclosure; Other Events
– Clinical efficacy continued to deepen over time with three SLE patients in DORIS remission, the first LN patient achieving complete renal response, and the first dermatomyositis patient maintaining a major TIS improvement; each of thes... |
| 14 Mar 2022 |
8-K/A: Regulation FD Disclosure
Disclaimer The following presentation, including any printed or electronic copy of these slides, the talks given by the presenters, the information communicated during any delivery of the presentation and any question and answer session ... |
Loading...